Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica

Background: Atrial fibrillation is associated to a high risk of systemic embolism and to hypercoagulability. Aim: To evaluate the activation of the coagulation cascade through determinations of the thrombin-antithrombin complex in patients with atrial fibrillation and to correlate this data with the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pérez P,Luis A, Corbalán H,Ramón, Acevedo B,Mónica, Pereira,Jaime, Braun J,Sandra, Tapia I,Jorge, Kramer Sch,Albrecht, Lira C,Mª Teresa, Huete,Isidro, Sepúlveda,Gonzalo, Springmüller,Daniel
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2002
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002001000002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872002001000002
record_format dspace
spelling oai:scielo:S0034-988720020010000022014-08-21Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémicaPérez P,Luis ACorbalán H,RamónAcevedo B,MónicaPereira,JaimeBraun J,SandraTapia I,JorgeKramer Sch,AlbrechtLira C,Mª TeresaHuete,IsidroSepúlveda,GonzaloSpringmüller,Daniel Arrhythmia Atrial fibrillation Coagulation protein disorders Embolism and thrombosis Background: Atrial fibrillation is associated to a high risk of systemic embolism and to hypercoagulability. Aim: To evaluate the activation of the coagulation cascade through determinations of the thrombin-antithrombin complex in patients with atrial fibrillation and to correlate this data with the clinical and echocardiographic risk factors for systemic embolism. Patients and Methods: In 53 patients with atrial fibrillation plasma levels of the thrombin-antithrombin complex were determined on admission to a coronary care unit and 30 days later. Using a univariate and multiple regression analysis, the association basal thrombin-antithrombin with the duration of the arrhythmia, age over 70 years, previous use of antiplatelet agents, history of hypertension, mitral valve disease, diabetes, heart failure, previous systemic embolism, left atrial diameter and the presence of spontaneous contrast echo or thrombus in the left atrial appendage, was studied. Results: Basal thrombin-antithrombin values were 40.1±69 mg/L (Median 8.34 [3.0-47.5]) compared to 2.7±3.3 mg/L in healthy controls (p <0.001). No significant correlation was found between activation of the coagulation cascade and risk factors for systemic embolism. There were no significant differences in thrombin-antithrombin values between patients with chronic or paroxysmal atrial fibrillation (29.5±43 mg/L and 49.4±83 mg/L respectively). Mean thrombin-antithrombin values in patients under antiplatelet agents were lower than in those without treatment (17.3±43 vs 66.8±127 mg/L; p=0.018). Conclusions: The activation of the coagulation cascade in patients with atrial fibrillation was confirmed. However, no association of this activation with well known clinical and echocardiographic risk factors for systemic embolism, was found. Previous antiplatelet treatment prevented a higher activation of the coagulation cascade (Rev Méd Chile 2002; 130: 1087-94)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.130 n.10 20022002-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002001000002es10.4067/S0034-98872002001000002
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Arrhythmia
Atrial fibrillation
Coagulation protein disorders
Embolism and thrombosis
spellingShingle Arrhythmia
Atrial fibrillation
Coagulation protein disorders
Embolism and thrombosis
Pérez P,Luis A
Corbalán H,Ramón
Acevedo B,Mónica
Pereira,Jaime
Braun J,Sandra
Tapia I,Jorge
Kramer Sch,Albrecht
Lira C,Mª Teresa
Huete,Isidro
Sepúlveda,Gonzalo
Springmüller,Daniel
Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
description Background: Atrial fibrillation is associated to a high risk of systemic embolism and to hypercoagulability. Aim: To evaluate the activation of the coagulation cascade through determinations of the thrombin-antithrombin complex in patients with atrial fibrillation and to correlate this data with the clinical and echocardiographic risk factors for systemic embolism. Patients and Methods: In 53 patients with atrial fibrillation plasma levels of the thrombin-antithrombin complex were determined on admission to a coronary care unit and 30 days later. Using a univariate and multiple regression analysis, the association basal thrombin-antithrombin with the duration of the arrhythmia, age over 70 years, previous use of antiplatelet agents, history of hypertension, mitral valve disease, diabetes, heart failure, previous systemic embolism, left atrial diameter and the presence of spontaneous contrast echo or thrombus in the left atrial appendage, was studied. Results: Basal thrombin-antithrombin values were 40.1±69 mg/L (Median 8.34 [3.0-47.5]) compared to 2.7±3.3 mg/L in healthy controls (p <0.001). No significant correlation was found between activation of the coagulation cascade and risk factors for systemic embolism. There were no significant differences in thrombin-antithrombin values between patients with chronic or paroxysmal atrial fibrillation (29.5±43 mg/L and 49.4±83 mg/L respectively). Mean thrombin-antithrombin values in patients under antiplatelet agents were lower than in those without treatment (17.3±43 vs 66.8±127 mg/L; p=0.018). Conclusions: The activation of the coagulation cascade in patients with atrial fibrillation was confirmed. However, no association of this activation with well known clinical and echocardiographic risk factors for systemic embolism, was found. Previous antiplatelet treatment prevented a higher activation of the coagulation cascade (Rev Méd Chile 2002; 130: 1087-94)
author Pérez P,Luis A
Corbalán H,Ramón
Acevedo B,Mónica
Pereira,Jaime
Braun J,Sandra
Tapia I,Jorge
Kramer Sch,Albrecht
Lira C,Mª Teresa
Huete,Isidro
Sepúlveda,Gonzalo
Springmüller,Daniel
author_facet Pérez P,Luis A
Corbalán H,Ramón
Acevedo B,Mónica
Pereira,Jaime
Braun J,Sandra
Tapia I,Jorge
Kramer Sch,Albrecht
Lira C,Mª Teresa
Huete,Isidro
Sepúlveda,Gonzalo
Springmüller,Daniel
author_sort Pérez P,Luis A
title Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
title_short Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
title_full Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
title_fullStr Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
title_full_unstemmed Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
title_sort hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
publisher Sociedad Médica de Santiago
publishDate 2002
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002001000002
work_keys_str_mv AT perezpluisa hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT corbalanhramon hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT acevedobmonica hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT pereirajaime hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT braunjsandra hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT tapiaijorge hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT kramerschalbrecht hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT liracmateresa hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT hueteisidro hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT sepulvedagonzalo hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
AT springmullerdaniel hipercoagulabilidadenfibrilacionauricularysurelacionconfactoresderiesgoparaemboliasistemica
_version_ 1718436059497365504